As global markets experience a boost from cooling inflation and robust bank earnings, value stocks have notably outperformed growth shares, particularly in the U.S. This environment presents an opportunity to explore stocks that may be undervalued, as investors seek to capitalize on sectors showing resilience and potential for recovery amidst these economic shifts. Top 10 Undervalued Stocks Based On Cash Flows Name Current Price Fair Value (Est) Discount (Est) Aidma Holdings (TSE:7373) ¥1753.00 ¥3613.36 51.5% Alltop Technology (TPEX:3526) NT$264.50 NT$526.96 49.8% Atlantic Union Bankshares (NYSE:AUB) US$37.87 US$75.40 49.8% Fevertree Drinks (AIM:FEVR) £6.575 £13.12 49.9% Sudarshan Chemical Industries (BSE:506655) ₹1112.30 ₹2216.41 49.8% Vestas Wind Systems (CPSE:VWS) DKK92.60 DKK184.75 49.9% Shinko Electric Industries (TSE:6967) ¥5850.00 ¥11654.66 49.8% St. James's Place (LSE:STJ) £9.315 £18.60 49.9% Condor Energies (TSX:CDR) CA$1.82 CA$3.63 49.8% Coeur Mining (NYSE:CDE) US$6.36 US$12.67 49.8% Click here to see the full list of 863 stocks from our Undervalued Stocks Based On Cash Flows screener. Here we highlight a subset of our preferred stocks from the screener. Bonesupport Holding Overview: Bonesupport Holding AB is an orthobiologics company that develops and commercializes injectable bio-ceramic bone graft substitutes across Europe, North America, and internationally, with a market cap of SEK24.81 billion. Operations: The company's revenue segment is primarily derived from Pharmaceuticals, amounting to SEK814.46 million. Estimated Discount To Fair Value: 22.8% Bonesupport Holding is trading at SEK 373.4, which is over 20% below its estimated fair value of SEK 483.97, indicating it may be undervalued based on discounted cash flow analysis. Despite a drop in profit margins from 41% to 11.1%, the company shows strong revenue growth forecasts of 33.8% annually, outpacing the Swedish market significantly. Recent positive clinical study results for CERAMENT products could further enhance its market position and drive future growth. The growth report we've compiled suggests that Bonesupport Holding's future prospects could be on the up. Click here to discover the nuances of Bonesupport Holding with our detailed financial health report.OM:BONEX Discounted Cash Flow as at Jan 2025 Guobo Electronics Overview: Guobo Electronics Co., Ltd. is involved in the R&D, production, and sale of active phased array transmitter and receiver components as well as radio frequency integrated circuit products in China, with a market cap of CN¥26.89 billion. Operations: Guobo Electronics generates revenue primarily through the sale of active phased array transmitter and receiver components and radio frequency integrated circuit products in China. Story Continues Estimated Discount To Fair Value: 12.9% Guobo Electronics, trading at CN¥46.89, is priced below its estimated fair value of CN¥53.85, suggesting undervaluation based on cash flows. Despite a decline in nine-month revenue to CN¥1.81 billion from the previous year's CN¥2.83 billion and net income dropping to CN¥306.41 million, earnings are forecasted to grow significantly at 26.9% annually over the next three years, outpacing both profit and revenue growth compared to the broader Chinese market. Insights from our recent growth report point to a promising forecast for Guobo Electronics' business outlook. Click here and access our complete balance sheet health report to understand the dynamics of Guobo Electronics.SHSE:688375 Discounted Cash Flow as at Jan 2025 Sodick Overview: Sodick Co., Ltd. develops, manufactures, and sells numerical control electric discharge machines (EDMs) and has a market cap of ¥40.75 billion. Operations: The company's revenue is primarily derived from its Machine Tool Business at ¥48.73 billion and Industrial Machinery at ¥8.76 billion, with additional contributions from the Food Machine segment totaling ¥5.86 billion. Estimated Discount To Fair Value: 28.6% Sodick, trading at ¥818, is undervalued compared to its estimated fair value of ¥1,145.62. Its earnings are expected to grow significantly by 92.47% annually over the next three years, surpassing market averages and leading to profitability. However, its return on equity is projected to remain low at 4.4%. Recent buyback activity totaling ¥176.1 million for 240,900 shares aims to enhance shareholder value amid a challenging business environment. Our comprehensive growth report raises the possibility that Sodick is poised for substantial financial growth. Get an in-depth perspective on Sodick's balance sheet by reading our health report here.TSE:6143 Discounted Cash Flow as at Jan 2025 Key Takeaways Reveal the 863 hidden gems among our Undervalued Stocks Based On Cash Flows screener with a single click here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide. Want To Explore Some Alternatives? Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include OM:BONEX SHSE:688375 and TSE:6143. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected] View Comments
3 Stocks That May Be Undervalued By Up To 28.6%
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more
Start Your Free Trial Now!Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...